Profile | GDS4304 / 218627_at |
Title | ATP effect on acute myeloid leukemia lymphoblasts |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM766225 | untreated AML 2B blasts | 180.375 | 76 |
GSM766227 | untreated AML 3 blasts | 418.466 | 88 |
GSM766229 | untreated AML 4B blasts | 102.649 | 69 |
GSM766226 | ATP-treated AML 2B blasts | 211.537 | 79 |
GSM766228 | ATP-treated AML 3 blasts | 671.411 | 92 |
GSM766230 | ATP-treated AML 4B blasts | 104.938 | 70 |
GSM766231 | untreated AML 6B blasts | 425.186 | 88 |
GSM766233 | untreated AML 7C blasts | 195.992 | 78 |
GSM766245 | untreated AML 13 blasts | 293.742 | 84 |
GSM766232 | ATP-treated AML 6B blasts | 264.567 | 83 |
GSM766234 | ATP-treated AML 7C blasts | 217.77 | 79 |
GSM766246 | ATP-treated AML 13 blasts | 417.432 | 88 |
GSM766235 | untreated AML 8 blasts | 778.013 | 93 |
GSM766237 | untreated AML 9 blasts | 1986.52 | 98 |
GSM766247 | untreated AML 14 blasts | 341.651 | 85 |
GSM766236 | ATP-treated AML 8 blasts | 457.422 | 89 |
GSM766238 | ATP-treated AML 9 blasts | 2369.62 | 98 |
GSM766248 | ATP-treated AML 14 blasts | 301.785 | 84 |
GSM766239 | untreated AML 10 blasts | 1061.81 | 95 |
GSM766241 | untreated AML 11 blasts | 953.097 | 94 |
GSM766243 | untreated AML 12 blasts | 542.762 | 90 |
GSM766240 | ATP-treated AML 10 blasts | 1241.16 | 96 |
GSM766242 | ATP-treated AML 11 blasts | 669.121 | 92 |
GSM766244 | ATP-treated AML 12 blasts | 537.658 | 90 |